Stay updated on AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial

Sign up to get notified when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The date has been updated from April 3, 2024, to March 7, 2025.
    Difference
    1.0%
    Check dated 2025-03-12T05:05:26.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-25T19:02:42.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-11T07:35:36.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-04T03:24:42.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-20T22:39:29.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T18:46:37.000Z thumbnail image

Stay in the know with updates to AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AK104 in First-line Treatment of G/GEJ AdenoCa Clinical Trial page.